サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1503249

尿検査の世界市場：製品 (消耗品・機器)別、検査タイプ (生化学・沈渣)別、用途 (尿路結石・糖尿病) 別 - 予測（～2029年）

Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029

出版日
ページ情報
英文 373 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
尿検査の世界市場：製品 (消耗品・機器)別、検査タイプ (生化学・沈渣)別、用途 (尿路結石・糖尿病) 別 - 予測（～2029年）
出版日: 2024年06月26日
発行: MarketsandMarkets
ページ情報: 英文 373 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

尿検査の市場規模は、2024年の43億米ドルから、予測期間中はCAGR 9.6%で推移し、2029年には68億米ドルの規模に成長すると予測されています。

調査範囲
調査対象年 2022-2029年
基準年 2023年
予測期間 2024-2029年
単位 金額（米ドル）
セグメント 製品・検査タイプ・用途・エンドユーザー別
対象地域 北米・欧州・アジア太平洋・ラテンアメリカ・中東&アフリカ・GCC諸国

高齢者人口の急速な増加により、糖尿病や肝臓・腎臓病など、加齢に伴う疾患の有病率は大幅に増加すると予想されています。このような疾患の診断と管理が、基礎代謝パネル、脂質プロファイル、肝臓・腎臓パネル検査の処方件数の増加の要因となっています。これらの検査は尿分析装置で実施されるため、市場成長にプラスの影響を与えます。世界の老年人口の増加は、尿検査市場の成長を促進する重要な要因と考えられています。

製品別では消耗品の部門が予測期間中にもっとも高い成長率を示す見通し：

尿検査市場の消耗品部門は大幅な成長を遂げています。これらの消耗品が繰り返し必要とされ、購入されることが、同部門の成長率が高い主な理由の1つです。また、尿検査市場で入手可能な消耗品の範囲が広いことも、この部門のシェア拡大に大きく寄与しています。尿検査市場では、さまざまな検査ニーズに対応する多様な消耗品が提供されています。より多くの検査パラメータを備えた新しいディップスティックの開発は、将来的にその需要をさらに増加させる見通しです。

用途別では、疾患スクリーニングの部門が予測期間中に最大の成長を示す見通し：

疾患スクリーニング部門は予測期間中にもっとも高いCAGRを示すと予想されています。尿検査はこのような疾患の診断に不可欠な役割を果たしているため、疾患スクリーニング用途は今後数年間で成長すると予想されています。早期の腎臓病や糖尿病など、尿検査で検出可能な多くの疾患は、進行するまで症状が現れないことが多いです。定期的な尿検査は早期発見と早期介入を可能にし、患者の予後を大幅に改善し、長期的なヘルスケアコストを削減します。このことは、尿検査が病気のスクリーニングに広く使用されることを後押しし、市場最大の部門としての地位を確実なものにすると考えられています。

アジア太平洋がもっとも急成長している地域市場に：

アジア太平洋地域は、最も高いCAGRを示すと予測されています。同地域の高成長は、疾病の早期発見に関する認識を高めるための政府の取り組みの増加、一人当たり所得の増加、アジア太平洋諸国の農村部への民間病院の拡大、同地域の高成長市場の存在などに起因しています。

当レポートでは、世界の尿検査の市場を調査し、市場概要、市場影響因子の分析、技術・特許の動向、法規制環境、ケーススタディ、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 価格分析
  • 特許分析
  • バリューチェーン分析
  • サプライチェーン分析
  • 貿易分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • 規制状況
  • 技術分析
  • 主な会議とイベント
  • 顧客の事業に影響を与える動向/ディスラプション
  • 主なステークホルダーと購入基準
  • 投資と資金調達のシナリオ
  • ケーススタディ分析
  • 尿検査市場におけるAIの影響

第6章 尿検査市場：製品別

  • 消耗品
    • 妊娠・不妊治療キット
    • ディップスティック
    • 試薬
    • 使い捨て品
  • 機器
    • 自動尿分析装置
    • 半自動尿分析装置
    • POC (ポイントオブケア) 尿分析装置

第7章 尿検査市場：検査タイプ別

  • 妊娠・生殖能力検査
  • 生化学検査
    • 臨床検査
    • POCテスト
  • 尿沈渣検査

第8章 尿検査市場：用途別

  • 疾患スクリーニング
    • 尿路感染症
    • 腎臓疾患
    • 糖尿病
    • 肝臓疾患
    • その他
  • 妊娠・生殖能力検査

第9章 尿検査市場：エンドユーザー別

  • 診断ラボ
  • 病院・クリニック
  • 在宅ケア
  • 研究機関

第10章 尿検査市場：地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • 概要
  • 主要企業の戦略/有力企業
  • 収益分析
  • 市場シェア分析
  • 企業評価マトリックス：主要企業
  • 企業評価マトリックス：スタートアップ/中小企業
  • 尿検査ベンダーの評価と財務指標
  • ブランド/製品比較分析
  • 競合シナリオ

第12章 企業プロファイル

  • 主要企業
    • SIEMENS HEALTHINEERS AG
    • F. HOFFMANN-LA ROCHE LTD.
    • CARDINAL HEALTH
    • DANAHER
    • ABBOTT
    • SYSMEX CORPORATION
    • THERMO FISHER SCIENTIFIC INC.
    • QUIDELORTHO CORPORATION
    • BECTON, DICKINSON AND COMPANY
    • BIO-RAD LABORATORIES, INC.
    • EKF DIAGNOSTICS HOLDINGS PLC
  • その他の企業
    • ARKRAY, INC.
    • ACON LABORATORIES, INC.
    • 77 ELEKTRONIKA KFT.
    • URIT MEDICAL ELECTRONIC CO., LTD.
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • DIRUI INDUSTRIAL CO., LTD.
    • BIOBASE GROUP
    • ERBA MANNHEIM
    • ALPHATEC SCIENTIFIC E.I.R.L.
    • TECO DIAGNOSTICS
    • ANALYTICON BIOTECHNOLOGIES GMBH
    • BIOWAY BIOLOGICAL TECHNOLOGY CO., LTD
    • HIGH TECHNOLOGY, INC.
    • AGAPPE DIAGNOSTICS LTD
    • TOYOBO CO., LTD.
    • DIALAB GMBH
    • QUANTIMETRIX
    • BIOCARE CORPORATION
    • RANDOX LABORATORIES LTD.
    • PZ CORMAY S.A.
    • YD DIAGNOSTICS
    • CONTEC MEDICAL SYSTEMS CO., LTD.
    • BIOPANDA REAGENTS LTD.

第13章 付録

目次
Product Code: MD 3259

The urinalysis market is valued at an estimated USD 4.3 billion in 2024 and is projected to reach USD 6.8 billion by 2029 at a CAGR of 9.6% during the forecast period.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Product, test type, application, and end user
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries

Due to rapid growth in the senior population, the prevalence of age-associated diseases such as diabetes and liver & kidney diseases is expected to increase significantly. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for the basic metabolic panel, lipid profile, and liver & renal panel tests. These tests are performed by urinalysis analyzers, thereby positively impacting market growth. The global rise in the geriatric population is considered a key factor in driving the growth of the urinalysis market.

"Consumables segment accounted for the highest growth rate in the urinalysis market, by product, during the forecast period."

Based on product, the urinalysis market is bifurcated into consumables and instruments. The consumables segment in the urinalysis market is experiencing substantial growth. The recurrent requirement and purchase of these consumables is one of the primary reasons for the high growth rate of this market segment. Also, the wider range of consumables available in the market for urinalysis is contributing significantly to its larger share. The urinalysis market offers variety of consumables catering to different testing needs. Development of new dipsticks with more test parameters will further increase their demand in future.

"Disease screening segment accounted for the highest growth rate in the urinalysis market, by application, during the forecast period."

The urinalysis market is bifurcated into disease screening and pregnancy & fertility testing. Disease screening segment is expected to account for the highest CAGR during the forecast period. As urinalysis plays an integral role in diagnosing such diseases, the urinalysis market for disease screening applications is expected to grow in the coming years. Additionally, many conditions detectable through urinalysis, such as early-stage kidney disease and diabetes, often do not exhibit symptoms until they are advanced. Regular urinalysis enables early detection and intervention, which can significantly improve patient outcomes and reduce long-term healthcare costs. This will bolster the extensive use of urinalysis in disease screening, ensuring its position as the largest segment in the market.

"Asia Pacific: The fastest-growing region in urinalysis market."

The worldwide market for urinalysis is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific region is poised to experience the most notable CAGR within the urinalysis market. The high growth in the Asia Pacific can be attributed to the increasing government efforts to increase awareness about early disease detection, growing per capita income, the expansion of private-sector hospitals to rural areas in various Asia Pacific countries, and the presence of high-growth markets in the region.

The break-up of the profile of primary participants in the urinalysis market:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%

The key players in this market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (US), Abbott (US), Danaher (US), Sysmex Corporation (Japan), Thermo Fisher Scientific Inc. (US), QuidelOrtho Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics Holdings plc (UK), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (US), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Co., Ltd. (China), DIRUI INDUSTRIAL CO., LTD. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), Erba Mannheim (UK), Alphatec Scientific E.I.R.L. (Peru), Teco Diagnostics (US), Analyticon Biotechnologies GmbH (Germany), Bioway Biological Technology Co., Ltd. (China), High Technology, Inc. (US), Agappe Diagnostics Ltd. (India), TOYOBO CO., LTD. (Japan), DIALAB GmbH (Austria), Quantimetrix (US), BioCare Corporation (Taiwan), Randox Laboratories Ltd. (Ireland), PZ Cormay S.A. (Poland), YD Diagnostics (South Korea), CONTEC MEDICAL SYSTEMS CO., LTD. (China), and Biopanda Reagents Ltd. (UK).

Research Coverage:

This research report categorizes the urinalysis market by product (Consumables [Pregnancy & Fertility Kits, Dipsticks, Disposables, Reagents], Instruments [Automated Urine Analyzers {Integrated Urine Analyzers, Sediment Urine Analyzers (Microscopy Analyzers, Flow Cytometry Analyzers), Biochemical Urine Analyzers, Semi-automated Urine Analyzers}, and Point-of-care Urine Analyzers], by test type (Pregnancy & Fertility Tests, Biochemical Tests [Laboratory Tests, PoC Tests], and Sediment Urinalysis), by application (Disease Screening [Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, and Other Disease Screening Applications] and Pregnancy & Fertility Testing), by end user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the urinalysis market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the urinalysis market. Competitive analysis of upcoming startups in the urinalysis market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urinalysis market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer, rising geriatric population and subsequent increase in age-associated diseases, and increasing adoption of PoC urine diagnostic tests), opportunities (Growth opportunities in emerging countries, technological advancements in urine analyzers, and increasing government initiatives and funding for preventive care), restraints (Availability of refurbished urine analyzers and high capital investments and lack of skilled laboratory technicians), and challenges (Changing regulatory landscape) influencing the growth of the urinalysis market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urinalysis market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the urinalysis market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urinalysis market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (US), Abbott (US), and Danaher (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS & EXCLUSIONS OF STUDY
  • 1.4 STUDY SCOPE
    • 1.4.1 MARKET SEGMENTATION
    • 1.4.2 REGIONS COVERED
    • 1.4.3 YEARS CONSIDERED
    • 1.4.4 CURRENCY CONSIDERED
  • 1.5 RESEARCH LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
  • 1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 1 URINALYSIS MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.3.1.3 Growth forecast
      • 2.3.1.4 CAGR projections
    • FIGURE 5 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 6 URINALYSIS MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 GROWTH RATE ASSUMPTIONS
  • 2.8 RISK ASSESSMENT
    • 2.8.1 URINALYSIS MARKET: RISK ASSESSMENT
  • 2.9 RECESSION IMPACT

3 EXECUTIVE SUMMARY

    • FIGURE 8 URINALYSIS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
    • FIGURE 9 URINALYSIS MARKET, BY TEST TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 10 URINALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 11 URINALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    • FIGURE 12 URINALYSIS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 URINALYSIS MARKET OVERVIEW
    • FIGURE 13 INCREASING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
  • 4.2 URINALYSIS MARKET SHARE, BY PRODUCT, 2024 VS. 2029
    • FIGURE 14 CONSUMABLES SEGMENT TO DOMINATE URINALYSIS PRODUCTS MARKET
  • 4.3 URINALYSIS MARKET SHARE, BY TEST TYPE, 2024 VS. 2029
    • FIGURE 15 PREGNANCY & FERTILITY TESTS SEGMENT TO DOMINATE MARKET
  • 4.4 URINALYSIS MARKET SHARE, BY APPLICATION, 2024 VS. 2029
    • FIGURE 16 DISEASE SCREENING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.5 URINALYSIS MARKET SHARE, BY END USER, 2024 VS. 2029
    • FIGURE 17 DIAGNOSTIC LABORATORIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
  • 4.6 URINALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 ASIA PACIFIC MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer
    • TABLE 1 ESTIMATED NUMBER OF ADULTS (20-79 YEARS) WITH DIABETES WORLDWIDE, BY REGION, 2021 VS. 2030 VS. 2045
      • 5.2.1.2 Rising geriatric population and subsequent increase in age-associated diseases
    • TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER, BY REGION, 2022 VS. 2030 VS. 2050
      • 5.2.1.3 Increasing adoption of PoC urine diagnostic tests
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Availability of refurbished urine analyzers
      • 5.2.2.2 High capital investments and lack of skilled laboratory technicians
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging countries
      • 5.2.3.2 Technological advancements in urine analyzers
      • 5.2.3.3 Increasing government initiatives and funding for preventive care
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Changing regulatory landscape
  • 5.3 PRICING ANALYSIS
    • TABLE 3 INDICATIVE PRICING FOR URINALYSIS PRODUCTS
    • TABLE 4 AVERAGE SELLING PRICE OF URINALYSIS PRODUCTS, BY REGION
  • 5.4 PATENT ANALYSIS
    • FIGURE 20 PATENT ANALYSIS FOR FLOW CYTOMETRY (JANUARY 2014-DECEMBER 2023)
    • 5.4.1 LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 21 VALUE CHAIN ANALYSIS OF URINALYSIS MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 22 URINALYSIS MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 TRADE ANALYSIS
    • 5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
    • TABLE 5 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 6 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.8 ECOSYSTEM ANALYSIS
    • FIGURE 23 URINALYSIS MARKET: ECOSYSTEM ANALYSIS
    • 5.8.1 URINALYSIS MARKET: ROLE IN ECOSYSTEM
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 24 URINALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 URINALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 BARGAINING POWER OF SUPPLIERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 REGULATORY LANDSCAPE
    • 5.10.1 NORTH AMERICA
      • 5.10.1.1 US
      • 5.10.1.2 Canada
    • 5.10.2 EUROPE
    • TABLE 8 EUROPE: CLASSIFICATION OF DEVICES
    • 5.10.3 ASIA PACIFIC
      • 5.10.3.1 China
      • 5.10.3.2 Japan
    • TABLE 9 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • 5.10.3.3 India
    • 5.10.4 LATIN AMERICA
      • 5.10.4.1 Brazil
      • 5.10.4.2 Mexico
    • 5.10.5 MIDDLE EAST
      • 5.10.5.1 Africa
    • 5.10.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TECHNOLOGY ANALYSIS
    • 5.11.1 KEY TECHNOLOGY
      • 5.11.1.1 Automated urine analyzers
    • 5.11.2 COMPLEMENTARY TECHNOLOGY
      • 5.11.2.1 Point-of-care urine analyzers
    • 5.11.3 ADJACENT TECHNOLOGY
      • 5.11.3.1 Multiplex PCR
  • 5.12 KEY CONFERENCES & EVENTS IN 2024-2025
    • TABLE 15 URINALYSIS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR URINALYSIS MARKET
    • FIGURE 25 REVENUE SHIFT IN URINALYSIS MARKET
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS
    • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS (%)
    • 5.14.2 BUYING CRITERIA
    • FIGURE 27 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS
    • TABLE 17 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS
  • 5.15 INVESTMENT & FUNDING SCENARIO
    • FIGURE 28 URINALYSIS MARKET: INVESTMENT & FUNDING SCENARIO
  • 5.16 CASE STUDY ANALYSIS
  • 5.17 IMPACT OF ARTIFICIAL INTELLIGENCE ON URINALYSIS MARKET

6 URINALYSIS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 18 URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • 6.1.1 PRIMARY NOTES
      • 6.1.1.1 Key industry insights
  • 6.2 CONSUMABLES
    • TABLE 19 KEY PRODUCTS IN URINALYSIS CONSUMABLES MARKET
    • TABLE 20 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 21 URINALYSIS CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 22 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 23 EUROPE: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 24 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 25 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1 PREGNANCY & FERTILITY KITS
      • 6.2.1.1 Rapid accessibility and testing convenience to drive market
    • TABLE 26 KEY PRODUCTS IN PREGNANCY & FERTILITY KITS MARKET
    • TABLE 27 PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 28 NORTH AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 29 EUROPE: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 30 ASIA PACIFIC: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 31 LATIN AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.2 DIPSTICKS
      • 6.2.2.1 Low cost to increase adoption
    • TABLE 32 KEY PRODUCTS IN URINALYSIS DIPSTICKS/URINE TEST STRIPS MARKET
    • TABLE 33 DIPSTICKS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 34 NORTH AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 35 EUROPE: DIPSTICKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 36 ASIA PACIFIC: DIPSTICKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 37 LATIN AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.3 REAGENTS
      • 6.2.3.1 Increasing use of controls and calibrators to drive market
    • TABLE 38 KEY PRODUCTS IN URINALYSIS REAGENTS MARKET
    • TABLE 39 REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 40 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 41 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 42 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 43 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.4 DISPOSABLES
      • 6.2.4.1 Wise usage in hospitals and clinical laboratories to support market growth
    • TABLE 44 DISPOSABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 45 NORTH AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 46 EUROPE: DISPOSABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: DISPOSABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 48 LATIN AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 49 KEY PRODUCTS IN URINALYSIS INSTRUMENTS MARKET
    • TABLE 50 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 51 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 52 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 53 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 54 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 55 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.1 AUTOMATED URINE ANALYZERS
    • TABLE 56 KEY PRODUCTS IN AUTOMATED URINE ANALYZERS MARKET
    • TABLE 57 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 58 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 59 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 60 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 61 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 62 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
      • 6.3.1.1 Integrated urine analyzers
        • 6.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers
    • TABLE 63 KEY PRODUCTS IN INTEGRATED URINE ANALYZERS MARKET
    • TABLE 64 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 65 NORTH AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 66 EUROPE: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 68 LATIN AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
      • 6.3.1.2 Sediment urine analyzers
    • TABLE 69 KEY PRODUCTS IN SEDIMENT URINE ANALYZERS MARKET
    • TABLE 70 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 71 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 72 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 73 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 74 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 75 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
        • 6.3.1.2.1 Flow cytometry analyzers
          • 6.3.1.2.1.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption
    • TABLE 76 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 77 NORTH AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 78 EUROPE: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 80 LATIN AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
        • 6.3.1.2.2 Microscopy analyzers
          • 6.3.1.2.2.1 Increased speed and accuracy of analysis to drive adoption
    • TABLE 81 MICROSCOPY ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 82 NORTH AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 83 EUROPE: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 85 LATIN AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
      • 6.3.1.3 Biochemical urine analyzers
        • 6.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market
    • TABLE 86 KEY PRODUCTS IN BIOCHEMICAL URINE ANALYZERS MARKET
    • TABLE 87 BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 88 NORTH AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 89 EUROPE: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 90 ASIA PACIFIC: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 91 LATIN AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.2 SEMI-AUTOMATED URINE ANALYZERS
      • 6.3.2.1 Extensive use in hospitals & clinics to drive segment growth
    • TABLE 92 KEY PRODUCTS IN SEMI-AUTOMATED URINE ANALYZERS MARKET
    • TABLE 93 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 94 NORTH AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 95 EUROPE: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 97 LATIN AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.3 POINT-OF-CARE URINE ANALYZERS
      • 6.3.3.1 Need for rapid testing to drive demand for PoC urine analyzers
    • TABLE 98 KEY PRODUCTS IN POINT-OF-CARE URINE ANALYZERS MARKET
    • TABLE 99 POC URINE ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 100 NORTH AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 101 EUROPE: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 102 ASIA PACIFIC: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 103 LATIN AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

7 URINALYSIS MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
    • TABLE 104 URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • 7.1.1 PRIMARY NOTES
      • 7.1.1.1 Key industry insights
  • 7.2 PREGNANCY & FERTILITY TESTS
    • 7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE MARKET
    • TABLE 105 KEY PRODUCTS IN PREGNANCY & FERTILITY TESTS MARKET
    • TABLE 106 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 107 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 108 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 109 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 110 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3 BIOCHEMICAL TESTS
    • TABLE 111 KEY PRODUCTS IN BIOCHEMICAL TESTS MARKET
    • TABLE 112 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 113 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 114 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 115 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 117 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 7.3.1 LABORATORY TESTS
      • 7.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market
    • TABLE 118 KEY PRODUCTS IN LABORATORY TESTS MARKET
    • TABLE 119 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 120 NORTH AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 121 EUROPE: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 123 LATIN AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 7.3.2 POC TESTS
      • 7.3.2.1 Convenience of PoC testing to drive segment growth
    • TABLE 124 KEY PRODUCTS IN POC TESTS MARKET
    • TABLE 125 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 126 NORTH AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 127 EUROPE: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 128 ASIA PACIFIC: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 129 LATIN AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.4 SEDIMENT URINALYSIS
    • 7.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET
    • TABLE 130 KEY PRODUCTS IN SEDIMENT URINALYSIS MARKET
    • TABLE 131 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 132 NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 133 EUROPE: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 134 ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 135 LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)

8 URINALYSIS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 136 URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • 8.1.1 PRIMARY NOTES
      • 8.1.1.1 Key industry insights
  • 8.2 DISEASE SCREENING
    • TABLE 137 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 138 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 139 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 140 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 142 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.1 URINARY TRACT INFECTIONS
      • 8.2.1.1 Increasing prevalence of UTIs to drive segment growth
    • TABLE 143 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 144 NORTH AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 145 EUROPE: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 146 ASIA PACIFIC: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 147 LATIN AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.2 KIDNEY DISEASES
      • 8.2.2.1 Rapidly growing geriatric population and increasing prevalence of kidney diseases to fuel segment growth
    • TABLE 148 TOTAL GERIATRIC POPULATION, 2022 VS. 2030 VS. 2050 (%)
    • TABLE 149 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 150 NORTH AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 151 EUROPE: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 152 ASIA PACIFIC: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 153 LATIN AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.3 DIABETES
      • 8.2.3.1 Development of advanced analytical tools to drive market
    • TABLE 154 ESTIMATED NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2021 VS. 2030 VS. 2045 (MILLION)
    • TABLE 155 TOP TEN COUNTRIES/TERRITORIES WITH HIGHEST TOTAL HEALTH EXPENDITURE (USD) DUE TO DIABETES IN 2021, 20-79 YEARS (USD BILLION)
    • TABLE 156 URINALYSIS MARKET FOR DIABETES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 157 NORTH AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 158 EUROPE: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 159 ASIA PACIFIC: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 160 LATIN AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.4 LIVER DISEASES
      • 8.2.4.1 High prevalence of liver diseases to support market growth
    • TABLE 161 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 162 NORTH AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 163 EUROPE: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 164 ASIA PACIFIC: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 165 LATIN AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.5 OTHER DISEASE SCREENING APPLICATIONS
    • TABLE 166 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 167 NORTH AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 168 EUROPE: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 169 ASIA PACIFIC: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 170 LATIN AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3 PREGNANCY & FERTILITY TESTING
    • 8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT
    • TABLE 171 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 172 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 173 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 174 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 175 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)

9 URINALYSIS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 176 URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2 DIAGNOSTIC LABORATORIES
    • 9.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET
    • TABLE 177 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 178 NORTH AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 179 EUROPE: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 180 ASIA PACIFIC: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 181 LATIN AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.3 HOSPITALS & CLINICS
    • 9.3.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO BOOST GROWTH
    • TABLE 182 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 183 NORTH AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 184 EUROPE: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 185 ASIA PACIFIC: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 186 LATIN AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.4 HOME CARE SETTINGS
    • 9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET
    • TABLE 187 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 188 NORTH AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 189 EUROPE: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 190 ASIA PACIFIC: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 191 LATIN AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.5 RESEARCH LABORATORIES & INSTITUTES
    • 9.5.1 DEVELOPMENT OF INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET
    • TABLE 192 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 193 NORTH AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 194 EUROPE: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 195 ASIA PACIFIC: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 196 LATIN AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)

10 URINALYSIS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 197 URINALYSIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 29 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
    • TABLE 198 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 199 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 200 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 201 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 202 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 203 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 204 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 205 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 206 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 207 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 208 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.2.1 NORTH AMERICA: RECESSION IMPACT
    • 10.2.2 US
      • 10.2.2.1 Rising prevalence of chronic diseases to drive market
    • TABLE 209 US: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 210 US: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 211 US: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 212 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 213 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 214 US: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 215 US: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 216 US: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 217 US: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 218 US: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Rising burden of CKD to augment market
    • TABLE 219 CANADA: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 220 CANADA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 221 CANADA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 222 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 223 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 224 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 225 CANADA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 226 CANADA: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 227 CANADA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 228 CANADA: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 229 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 230 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 231 EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 232 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 233 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 234 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 235 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 236 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 237 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 238 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 239 EUROPE: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.1 EUROPE: RECESSION IMPACT
    • 10.3.2 GERMANY
      • 10.3.2.1 Increasing healthcare expenditure to fuel market growth
    • TABLE 240 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 241 GERMANY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 242 GERMANY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 243 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 244 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 245 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 246 GERMANY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 247 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 248 GERMANY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 249 GERMANY: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Rising government healthcare expenditure to propel market
    • TABLE 250 UK: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 251 UK: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 252 UK: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 253 UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 254 UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 255 UK: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 256 UK: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 257 UK: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 258 UK: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 259 UK: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.4 FRANCE
      • 10.3.4.1 High R&D expenditure to provide growth opportunities
    • TABLE 260 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 261 FRANCE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 262 FRANCE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 263 FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 264 FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 265 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 266 FRANCE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 267 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 268 FRANCE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 269 FRANCE: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Rising prevalence of diabetes to drive market
    • TABLE 270 ITALY: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 271 ITALY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 272 ITALY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 273 ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 274 ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 275 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 276 ITALY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 277 ITALY: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 278 ITALY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 279 ITALY: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Growing elderly population to propel market
    • TABLE 280 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 281 SPAIN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 282 SPAIN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 283 SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 284 SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 285 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 286 SPAIN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 287 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 288 SPAIN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 289 SPAIN: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.7 RUSSIA
      • 10.3.7.1 Long-term healthcare investment initiatives by government to support market growth
    • TABLE 290 RUSSIA: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 291 RUSSIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 292 RUSSIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 293 RUSSIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 294 RUSSIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 295 RUSSIA: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 296 RUSSIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 297 RUSSIA: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 298 RUSSIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 299 RUSSIA: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.8 REST OF EUROPE
    • TABLE 300 DEATHS DUE TO KIDNEY DISEASES PER 100,000 POPULATION, BY COUNTRY, 2020
    • TABLE 301 REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 302 REST OF EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 303 REST OF EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 304 REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 305 REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 306 REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 307 REST OF EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 308 REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 309 REST OF EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 310 REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 30 ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT
    • TABLE 311 ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 312 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 313 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 314 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 315 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 316 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 317 ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 318 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 319 ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 320 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 321 ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
    • 10.4.2 CHINA
      • 10.4.2.1 Improving healthcare infrastructure to support market growth
    • TABLE 322 CHINA: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 323 CHINA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 324 CHINA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 325 CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 326 CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 327 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 328 CHINA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 329 CHINA: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 330 CHINA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 331 CHINA: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.3 JAPAN
      • 10.4.3.1 Favorable regulatory framework to drive market growth
    • TABLE 332 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 333 JAPAN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 334 JAPAN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 335 JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 336 JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 337 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 338 JAPAN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 339 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 340 JAPAN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 341 JAPAN: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 Increasing investments in healthcare system to drive market
    • TABLE 342 INDIA: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 343 INDIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 344 INDIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 345 INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 346 INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 347 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 348 INDIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 349 INDIA: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 350 INDIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 351 INDIA: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Rising prevalence of chronic diseases to propel market
    • TABLE 352 AUSTRALIA: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 353 AUSTRALIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 354 AUSTRALIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 355 AUSTRALIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 356 AUSTRALIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 357 AUSTRALIA: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 358 AUSTRALIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 359 AUSTRALIA: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 360 AUSTRALIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 361 AUSTRALIA: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Growing medical tourism to drive demand for urinalysis
    • TABLE 362 SOUTH KOREA: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 363 SOUTH KOREA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 364 SOUTH KOREA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 365 SOUTH KOREA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 366 SOUTH KOREA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 367 SOUTH KOREA: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 368 SOUTH KOREA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 369 SOUTH KOREA: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 370 SOUTH KOREA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 371 SOUTH KOREA: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.7 REST OF ASIA PACIFIC
    • TABLE 372 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 373 REST OF ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 374 REST OF ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 375 REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 376 REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 377 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 378 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 379 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 380 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 381 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 382 LATIN AMERICA: URINALYSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 383 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 384 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 385 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 386 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 387 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 388 LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 389 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 390 LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 391 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 392 LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.5.1 LATIN AMERICA: RECESSION IMPACT
    • 10.5.2 BRAZIL
      • 10.5.2.1 Largest healthcare market in Latin America
    • TABLE 393 BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 394 BRAZIL: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 395 BRAZIL: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 396 BRAZIL: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 397 BRAZIL: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 398 BRAZIL: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 399 BRAZIL: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 400 BRAZIL: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 401 BRAZIL: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 402 BRAZIL: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.5.3 MEXICO
      • 10.5.3.1 Popularity in medical tourism to drive market growth
    • TABLE 403 MEXICO: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 404 MEXICO: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 405 MEXICO: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 406 MEXICO: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 407 MEXICO: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 408 MEXICO: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 409 MEXICO: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 410 MEXICO: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 411 MEXICO: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 412 MEXICO: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.5.4 REST OF LATIN AMERICA
    • TABLE 413 REST OF LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 414 REST OF LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 415 REST OF LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 416 REST OF LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 417 REST OF LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 418 REST OF LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 419 REST OF LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 420 REST OF LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 421 REST OF LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 422 REST OF LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 UNFAVORABLE REIMBURSEMENT POLICIES TO RESTRAIN MARKET GROWTH
    • TABLE 423 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 424 MIDDLE EAST & AFRICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 425 MIDDLE EAST & AFRICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 426 MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 427 MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 428 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 429 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 430 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 431 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 432 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • 10.7 GCC COUNTRIES
    • 10.7.1 RISING HEALTHCARE EXPENDITURE AND SUPPORTIVE GOVERNMENT INITIATIVES TO PROPEL MARKET
    • TABLE 433 GCC COUNTRIES: URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 434 GCC COUNTRIES: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 435 GCC COUNTRIES: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 436 GCC COUNTRIES: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 437 GCC COUNTRIES: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 438 GCC COUNTRIES: URINALYSIS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 439 GCC COUNTRIES: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 440 GCC COUNTRIES: URINALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 441 GCC COUNTRIES: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 442 GCC COUNTRIES: URINALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.7.2 GCC COUNTRIES: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN URINALYSIS MARKET
    • TABLE 443 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • 11.3 REVENUE ANALYSIS
    • FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN URINALYSIS MARKET, 2021-2023 (USD MILLION)
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS IN URINALYSIS MARKET (2023)
    • TABLE 444 URINALYSIS MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 33 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
    • FIGURE 34 URINALYSIS MARKET: COMPANY FOOTPRINT
      • 11.5.5.2 Product footprint
    • TABLE 445 URINALYSIS MARKET: PRODUCT FOOTPRINT
      • 11.5.5.3 Region footprint
    • TABLE 446 URINALYSIS MARKET: REGION FOOTPRINT
      • 11.5.5.4 Application footprint
    • TABLE 447 URINALYSIS MARKET: APPLICATION FOOTPRINT
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • FIGURE 35 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
    • 11.6.5 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, 2023
    • TABLE 448 URINALYSIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
    • TABLE 449 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
  • 11.7 VALUATION AND FINANCIAL METRICS OF URINALYSIS VENDORS
    • FIGURE 36 EV/EBITDA OF KEY VENDORS
    • FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • 11.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
    • FIGURE 38 BRAND/PRODUCT COMPARISON: URINE ANALYZERS
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • TABLE 450 URINALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024
    • 11.9.2 DEALS
    • TABLE 451 URINALYSIS MARKET: DEALS, JANUARY 2021-MAY 2024
    • 11.9.3 EXPANSIONS
    • TABLE 452 URINALYSIS MARKET: EXPANSIONS, JANUARY 2021-MAY 2024

12 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) **
  • 12.1 KEY PLAYERS
    • 12.1.1 SIEMENS HEALTHINEERS AG
    • TABLE 453 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
    • FIGURE 39 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
    • TABLE 454 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
    • TABLE 455 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021-MAY 2024
    • TABLE 456 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021-MAY 2024
    • 12.1.2 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 457 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
    • FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
    • TABLE 458 F. HOFFMAN-LA ROCHE LTD.: PRODUCTS OFFERED
    • 12.1.3 CARDINAL HEALTH
    • TABLE 459 CARDINAL HEALTH: COMPANY OVERVIEW
    • FIGURE 41 CARDINAL HEALTH: COMPANY SNAPSHOT (2023)
    • TABLE 460 CARDINAL HEALTH: PRODUCTS OFFERED
    • TABLE 461 CARDINAL HEALTH: EXPANSIONS, JANUARY 2021-MAY 2024
    • 12.1.4 DANAHER
    • TABLE 462 DANAHER: COMPANY OVERVIEW
    • FIGURE 42 DANAHER: COMPANY SNAPSHOT (2023)
    • TABLE 463 DANAHER: PRODUCTS OFFERED
    • TABLE 464 DANAHER: DEALS, JANUARY 2021-MAY 2024
    • TABLE 465 DANAHER: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024
    • 12.1.5 ABBOTT
    • TABLE 466 ABBOTT: COMPANY OVERVIEW
    • FIGURE 43 ABBOTT: COMPANY SNAPSHOT (2023)
    • TABLE 467 ABBOTT: PRODUCTS OFFERED
    • 12.1.6 SYSMEX CORPORATION
    • TABLE 468 SYSMEX CORPORATION: COMPANY OVERVIEW
    • FIGURE 44 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 469 SYSMEX CORPORATION: PRODUCTS OFFERED
    • TABLE 470 SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024
    • TABLE 471 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2021-MAY 2024
    • 12.1.7 THERMO FISHER SCIENTIFIC INC.
    • TABLE 472 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
    • FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
    • TABLE 473 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
    • TABLE 474 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-MAY 2024
    • 12.1.8 QUIDELORTHO CORPORATION
    • TABLE 475 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
    • FIGURE 46 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023)
    • TABLE 476 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
    • TABLE 477 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021-MAY 2024
    • 12.1.9 BECTON, DICKINSON AND COMPANY
    • TABLE 478 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
    • FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
    • TABLE 479 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
    • 12.1.10 BIO-RAD LABORATORIES, INC.
    • TABLE 480 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
    • FIGURE 48 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
    • TABLE 481 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
    • 12.1.11 EKF DIAGNOSTICS HOLDINGS PLC
    • TABLE 482 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY OVERVIEW
    • FIGURE 49 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY SNAPSHOT (2023)
    • TABLE 483 EKF DIAGNOSTICS HOLDINGS PLC: PRODUCTS OFFERED
  • 12.2 OTHER PLAYERS
    • 12.2.1 ARKRAY, INC.
    • 12.2.2 ACON LABORATORIES, INC.
    • 12.2.3 77 ELEKTRONIKA KFT.
    • 12.2.4 URIT MEDICAL ELECTRONIC CO., LTD.
    • 12.2.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 12.2.6 DIRUI INDUSTRIAL CO., LTD.
    • 12.2.7 BIOBASE GROUP
    • 12.2.8 ERBA MANNHEIM
    • 12.2.9 ALPHATEC SCIENTIFIC E.I.R.L.
    • 12.2.10 TECO DIAGNOSTICS
    • 12.2.11 ANALYTICON BIOTECHNOLOGIES GMBH
    • 12.2.12 BIOWAY BIOLOGICAL TECHNOLOGY CO., LTD
    • 12.2.13 HIGH TECHNOLOGY, INC.
    • 12.2.14 AGAPPE DIAGNOSTICS LTD
    • 12.2.15 TOYOBO CO., LTD.
    • 12.2.16 DIALAB GMBH
    • 12.2.17 QUANTIMETRIX
    • 12.2.18 BIOCARE CORPORATION
    • 12.2.19 RANDOX LABORATORIES LTD.
    • 12.2.20 PZ CORMAY S.A.
    • 12.2.21 YD DIAGNOSTICS
    • 12.2.22 CONTEC MEDICAL SYSTEMS CO., LTD.
    • 12.2.23 BIOPANDA REAGENTS LTD.
  • *Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS